Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Wed, 09th Dec 2020 16:08

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Wizz Air Holdings PLC - Budapest-based budget airline - Hires Robert Carey as president, starting June 14 next year, to oversee operations and commercial functions. Carey has been chief commercial & strategy officer for rival carrier easyJet PLC since 2017, having started at America West Airlines followed by Delta Airlines and a 10-year stint at McKinsey & Co. Wizz also hires Michael Delehant as executive vice president and chief operations officer, reporting to Carey. Delehant joins from Vueling, the Spanish low-cost airline owned by International Consolidated Airlines Group SA, where he has been chief strategy & network officer. He starts at Wizz on April 1.

----------

Cenkos Securities PLC - London-based stock broker and company advisor - Jim Durkin will retire as chief executive in March of next year, after having returned to Cenkos in 2019. That was a difficult time for UK stockbrokers, Cenkos notes, and Durkin "kept the company profitable, led the restructuring of the board and further strengthened governance". Julian Morse, an executive director and head of the Growth Companies Team, will replace Durkin as CEO. Cenkos says Morse is a founding member of the Growth Companies Team and has led it since 2016. Cenkos also promotes Jeremy Osler, co-head of Corporate Finance & general counsel, to the board as an executive director. Osler joined Cenkos in 2016.

----------

London Stock Exchange Group PLC - trading and clearing operator and index calculator - Proposes Martin Brand, Erin Brown and Douglas Steenland as board directors. The appointments are part of LSEG's acquisition of market data and trading platform provider Refinitiv, following which the shareholders of Refinitiv will have the right to nominate three non-executive directors for as long as they continue to hold at least 25% of LSEG. Brand and Steenland will represent Blackstone, and Brown will represent Thomson Reuters. Brand is a senior managing director and co-head of US Acquisitions for Blackstone's Private Equity Group. Steenland is a a senior adviser to the Blackstone Private Equity Group. Brown is head of Finance for the Thomson Reuters Corporates segment. LSEG expects the Refinitiv acquisition to complete in the first quarter of next year.

----------

Aviva PLC - London-based life and general insurer - Hires Pippa Lambert as independent non-executive director, starting January 1. Lambert was global head of Human Resources at Deutsche Bank AG and before that head of Reward at Royal Bank of Scotland.

----------

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Hires Christopher Brinsmead as director. Brinsmead was president of AstraZeneca UK & Ireland, part of AstraZeneca PLC, until 2010 and before that president of the Association of the British Pharamaceutical Industry.

----------

Network International Holdings PLC - Middle East-focused payment solutions provider - Hires Diane Radley and Monique Shivanandan as independent non-executive directors, starting January 1. Radley led the Transaction Services Group at PwC South Africa. She also was CEO of Old Mutual Investment Group from 2011 to 2016, having been finance director prior to that. Shivanandan is chief information officer at property and casualty insurance firm Chubb Ltd and also a non-executive director for JP Morgan Securities in the UK.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Feb 2020 09:09

OptiBiotix Health signs North American distribution agreement for LPLDL

(Sharecast News) - Life sciences business OptiBiotix Health has inked a distribution agreement with Advanced NutriSolutions/Select Ingredient for the exclusive sale of its patented probiotic strain LPLDL in the United States and Canada.

Read more
12 Feb 2020 10:40

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

OptiBiotix Health Inks Licencing Deal For Yoghurt With LPLDL Probiotic

Read more
12 Feb 2020 09:11

OptiBiotix strikes deal for proprietary probiotic yoghurt

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has signed a licencing agreement with Granja Pocha for the inclusion of its patented probiotic strain, 'LPLDL', into a functional yoghurt product in Uruguay.

Read more
31 Jan 2020 15:29

OptiBiotix, Agropur Launch SlimBiome Product In North America

OptiBiotix, Agropur Launch SlimBiome Product In North America

Read more
31 Jan 2020 08:57

OptiBiotix and partner Agropur launch 'SlimBiome' in North America

(Sharecast News) - Life sciences company OptiBiotix Health and its partner Agropur announced the launch of 'SlimBiome' in the North American market on Friday.

Read more
28 Jan 2020 13:02

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

OptiBiotix Health Expands SlimBiome And GoFigure Distribution Deals

Read more
27 Jan 2020 09:50

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

AlfaSigma To Launch New Supplement Containing OptiBiotix Probiotic

Read more
17 Jan 2020 10:32

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

OptiBiotix Health Aims For Profit In 2020; Explores Nasdaq Listing

Read more
17 Jan 2020 08:08

OptiBiotix eyes profitability in 2020, explores Nasdaq listing

(Sharecast News) - Life sciences business OptiBiotix Health provided revenue guidance for its recently wrapped up trading year on Friday and told investors it was now eyeing up a dual-listing on the New York Stock Exchange as it forecast profitability in 2020.

Read more
8 Jan 2020 15:56

OptiBiotix Health reports successful results from hypertension study

(Sharecast News) - Life sciences business OptiBiotix Health announced on Wednesday that its fully-owned subsidiary ProBiotix Health, in partnership with Nutrilinea, has completed a successful human study for a new food supplement formulation containing 'LPLDL', and showed that the product could reduce high blood pressure, or hypertension.

Read more
8 Jan 2020 10:42

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

OptiBiotix Health's LPLDL Product Reduces Hypertension In Study

Read more
7 Jan 2020 08:58

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Holland & Barrett Launching Product Containing OptiBiotix's SlimBiome

Read more
19 Dec 2019 12:25

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

OptiBiotix Inks New SlimBiome Distribution Deal In Germany

Read more
17 Dec 2019 13:44

OptiBiotix Health launches two products with partners in India

(Sharecast News) - Life sciences company OptiBiotix Health announced the commercial launch of two products formulated with its 'SlimBiome' product in the Indian market on Tuesday, in partnership with Anthem BioPharma and Zeon Life Sciences.

Read more
17 Dec 2019 12:25

OptiBiotix Health Launches Two SlimBiome-Based Products In India

OptiBiotix Health Launches Two SlimBiome-Based Products In India

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.